Atlas Trials

A Pilot Bioequivalence Study of Pomalidomide

Clinical trial NCT03424928 · COMPLETED

Trial details

NCT number
NCT03424928
Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Bioequivalence
Start date
2018-01-19
Primary completion
2018-01-29
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.